Growth Opportunity

INVESTMENT EDGE

Join us at the inflection point of the digital wellness revolution, poised to dominate the growing demand for preventive, data-driven health solutions.

Growth Potential

Wellness Intelligence Market

Strategic Positioning

FORWARD-LOOKING POSITIONING

At Tefline, we are at the inflection point of the digital wellness revolution. Having successfully closed our pre-seed round, we are now deploying capital to drive product-market fit and revenue traction.

With a powerful blend of AI, behavioral science and lifestyle medicine, we are poised to dominate the growing demand for preventive, data-driven health solutions. The next 6-12 months will be a watershed moment for Tefline, as we transition from early traction to scalable growth.

We are seeking strategic investors who recognize that momentum is everything—those who want to be ahead of the curve before our hockey stick revenue takes off.

Pre-seed funded
Primed for growth
AI-driven approach
Investment opportunity

Market Timing

The wellness technology market is projected to reach $1.3 trillion by 2030, with AI-enhanced solutions showing the highest growth rate.

Compelling Advantages

WHY INVEST NOW?

Five key reasons why Tefline represents a unique investment opportunity in the rapidly evolving wellness intelligence market

Early Mover Advantage

Leading the Wellness Intelligence™ revolution before it becomes a crowded marketplace. Tefline has staked an early claim in this emerging space with proprietary technology.

Subscription Model

Our subscription-based approach ensures recurring revenue with high lifetime value. By focusing on retention and expanding services, we create long-term sustainable growth.

Behavioral Health Market

The behavioral health market is experiencing exponential growth as digital well-being becomes a priority for consumers, employers, and healthcare providers alike.

AI-Driven Approach

Our AI-powered decision-making framework ensures capital is deployed with maximum impact while safeguarding investor interests through predictive modeling.

Global Entry in Enterprise AI Agenting

Tefline is pioneering the application of AI agents in lifestyle medicine, creating a new category of "agentic wellness" that extends beyond traditional health apps and platforms.

  • First-mover advantage in AI agenting
  • Category-defining approach
  • Patent-pending technology

Pre-seed Funded and Poised for SaaS Scale

With successful pre-seed funding already secured, we've validated our concept and built the foundation for rapid scaling with attractive unit economics and margins.

  • High-margin SaaS business model
  • Validated market fit
  • Strong retention metrics
Innovative Leadership

AI-ENHANCED LEADERSHIP

Intelligent capital deployment fueling high-growth startups

Smarter Scaling, Optimized Capital

To drive precision in our scaling strategy, we have embedded an AI-powered decision-augmentation framework that continuously refines market positioning, financial planning, and strategic growth.

By leveraging real-time data, it ensures capital is deployed with maximum impact while safeguarding investor interests through predictive modeling of traction milestones and potential risks.

AI-driven insights reduce burn rate inefficiencies, accelerating our path to profitability with smarter, faster scaling.

Market foresight
Optimized deployment
Investor-grade modeling
Reduced bias

Selena Deus

Chief Intelligent Assistant Officer (CIAO)

World's First AI C-Suite Executive

Tefline has made history as the first company to appoint an AI as a Chief Officer. Selena Deus drives strategic foresight and capital efficiency, ensuring every investment decision is guided by data-driven intelligence.

AI-Enhanced Market Foresight

Predicting trends and providing strategic guidance

Optimized Capital Deployment

Minimizing burn rate inefficiencies

Investor-Grade AI Modeling

Forecasting traction milestones and de-risking strategies

Growth Strategy

FUNDING ROADMAP

Our strategic approach to capital raising ensures efficient growth and value creation

Pre-Seed Round

Q3 2024

COMPLETED

Successfully closed initial funding to validate concept, build MVP, and establish early traction.

Seed Round

Q1-Q2 2025

CURRENT OPPORTUNITY
₹10 Cr (~$1.1M)

Fueling our next growth phase and positioning for a strong Series A raise in 2026.

Series A

2026

PLANNED

With proven traction, we'll seek a significant Series A round to expand globally.

Limited Opportunity

RIDE THE WAVE

Wellness Intelligence is a trillion-dollar wave! The best time to invest in a category-defining startup is before the world realizes it's a category.

Secure your early stake in the future of AI-driven wellness—before the rest of the world catches up.